ResMed shares are up 42% in a year. This shows why they could still be great value
Up 42% in a year, not including dividends, here’s why ResMed Inc (ASX: RMD) shares can keep charging ahead in 2025.
Jezebel23h
CES Used to Promote Gadgets. This Year It Promoted a Future Shaped—and Ruined—By AI.
Jezebel has been the Internet's most treasured source for everything celebrities, sex, and politics...with teeth.
Biologic Pharmamedical Launches Innovative Functional Beverages for Health, Longevity, and Performance
Biologic Pharmamedical invites wellness brands, MLMs, and co-manufacturers to explore how these patented technologies can revolutionize their product lines. From formulation to marketing, Biologic ...
News Medical on MSN8h
Semaglutide improves glycemic control with automated insulin delivery
Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...
As Lilly Stock Tumble on GLP-1 Demand Worries, CEO Says All Is Well
Sales results disclosed Tuesday raised concern that investors may have overestimated the demand for Zepbound and Mounjaro.